Paper39124690
Turning the Tide against Herpes Zoster in Rheumatoid Arthritis Patients Treated with JAK Inhibitors.
Cito A and 6 others. J Clin Med, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Turning the Tide against Herpes Zoster in Rheumatoid Arthritis Patients Treated with JAK Inhibitors. Papers, record 39124690. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39124690
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Turning the Tide against Herpes Zoster in Rheumatoid Arthritis Patients Treated with JAK Inhibitors.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22873531 | Tofacitinib or adalimumab versus placebo in rheumatoid arthritis. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22873531 | PubMed |
| 2 | 12209125 | Stats: transcriptional control and biological impact. | Nat Rev Mol Cell Biol | 2002 | https://conductscience.org/library/papers/12209125 | PubMed |
| 3 | 26990731 | Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination. | Arthritis Rheumatol | 2016 | https://conductscience.org/library/papers/26990731 | PubMed |
| 4 | 23740236 | Evaluation of the RABBIT Risk Score for serious infections. | Ann Rheum Dis | 2014 | https://conductscience.org/library/papers/23740236 | PubMed |
| 5 | 31287230 | Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double-Blind, Randomized Controlled Trial. | Arthritis Rheumatol | 2019 | https://conductscience.org/library/papers/31287230 | PubMed |
| 6 | 29081988 | Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme. | RMD Open | 2017 | https://conductscience.org/library/papers/29081988 | PubMed |
| 7 | 33763912 | Cigarette smoking and risk of herpes zoster: a population-based cohort study in Taiwan. | Clin Exp Dermatol | 2021 | https://conductscience.org/library/papers/33763912 | PubMed |
| 8 | 34706874 | Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database. | Ann Rheum Dis | 2022 | https://conductscience.org/library/papers/34706874 | PubMed |
| 9 | 28130918 | Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus. | Arthritis Rheumatol | 2017 | https://conductscience.org/library/papers/28130918 | PubMed |
| 10 | 18505138 | Herpes zoster in eastern Saudi Arabia: clinical presentation and management. | J Drugs Dermatol | 2008 | https://conductscience.org/library/papers/18505138 | PubMed |
| 11 | 34671868 | Adverse Effects of Immunosuppression: Infections. | Handb Exp Pharmacol | 2022 | https://conductscience.org/library/papers/34671868 | PubMed |
| 12 | 17676033 | Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. | Nature | 2007 | https://conductscience.org/library/papers/17676033 | PubMed |
| 13 | 29568506 | Recent advances in antiviral interferon-stimulated gene biology. | F1000Res | 2018 | https://conductscience.org/library/papers/29568506 | PubMed |
| 14 | 29079160 | Herpes Zoster in the Older Adult. | Infect Dis Clin North Am | 2017 | https://conductscience.org/library/papers/29079160 | PubMed |
| 15 | 26478818 | Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. | Ther Adv Vaccines | 2015 | https://conductscience.org/library/papers/26478818 | PubMed |
| 16 | 15471658 | Treatment of postherpetic neuralgia: a review of therapeutic options. | J Pain Symptom Manage | 2004 | https://conductscience.org/library/papers/15471658 | PubMed |
| 17 | 6195526 | Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus. | N Engl J Med | 1983 | https://conductscience.org/library/papers/6195526 | PubMed |
| 18 | 35215786 | Herpes zoster: A Review of Clinical Manifestations and Management. | Viruses | 2022 | https://conductscience.org/library/papers/35215786 | PubMed |
| 19 | 37108130 | Immunogenicity and Safety of Adjuvanted Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients on Anti-Cellular Biologic Agents or JAK Inhibitors: A Prospective Observational Study. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108130 | PubMed |
| 20 | 26611557 | Infection Risk and Safety of Corticosteroid Use. | Rheum Dis Clin North Am | 2016 | https://conductscience.org/library/papers/26611557 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42194695 | Herpes Zoster in Patients Treated with JAK Inhibitors for Immune-Mediated Inflammatory Diseases: Incidence, Associated Factors and Vaccination Uptake in a Real-World Cohort. | J Clin Med | 2026 | https://conductscience.org/library/papers/42194695 | PubMed |
| 42183272 | Prevalence and risk factors of herpes zoster in patients with rheumatoid arthritis: a systematic review and meta-analysis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42183272 | PubMed |
| 41710062 | Herpes Zoster Risk in Rheumatoid Arthritis Patients on Janus Kinase Inhibitors: A 17-Year Experience from Rheumatoid Arthritis Saudi Database (RASD). | Open Access Rheumatol | 2026 | https://conductscience.org/library/papers/41710062 | PubMed |
| 41441693 | Effectiveness and Safety of Recombinant Zoster Vaccine in Rheumatic Diseases: Real-World Evidence from a Single-Centre Italian Cohort. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41441693 | PubMed |
| 41371648 | Preventive Effectiveness of Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients Treated with Janus Kinase Inhibitors. | Intern Med | 2026 | https://conductscience.org/library/papers/41371648 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39124690
GET https://conductscience.org/api/papers/v1/39124690/references?page=2